Synapse - Martin Voss

Results (294)

CX-839-004: A phase I/II study of the safety, pharmacokinetics, and pharmacodynamics of the glutaminase inhibitor CB-839 combined with nivolumab in patients with renal cell carcinoma, melanoma, and non-small cell lung cancer

Meeting Abstract

Lam, E.; Tannir, N. M.; Meric-Bernstam, F.; Vaishampayan, U.; Orford, K. W.; Molineaux, C.; Gross, M.; MacKinnon, A.; Voss, M.
Journal for ImmunoTherapy of Cancer (2016)

Fulltext@MSK | Save

Phase I study of everolimus in combination with gemcitabine and split-dose cisplatin in advanced urothelial carcinoma

Journal Article

Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Voss, M. H.; Apolo, A. B.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; more...
Bladder Cancer (2016)

Fulltext@MSK | Save

Updated results from a phase I study of nivolumab (nivo) in combination with ipilimumab (ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study

Meeting Abstract

Hammers, H.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D.; Lewis, L.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)

Meeting Abstract

Meric-Bernstam, F.; Tannir, N.; Harding, J.; Voss, M.; Mier, J.; DeMichele, A.; Munster, P.; Patel, M.; Iliopoulos, O.; Owonikoko, T.; more...
European Journal of Cancer (2016)

Fulltext@MSK | Save

Updated results from a phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma: The CheckMate 016 study

Meeting Abstract

Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D. F.; Lewis, L. D.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A.; more...
BJU International (2016)

Fulltext@MSK | Save

A randomized phase 2 trial of CRLX101 in combination with bevacizumab in patients with metastatic renal cell carcinoma (mRCC) versus standard of care (SOC)

Meeting Abstract

Voss, M.; Hutson, T. E.; Hussain, A.; Vaishampayan, U.; Vogelzang, N. J.; Crowell, T.; Li, J.; Downing, W.; Senderowicz, A.; Stone, E.
BJU International (2016)

Fulltext@MSK | Save

Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes

Meeting Abstract

Lee, C. H.; Carlo, M.; Chen, Y.; Chaim, J.; Coskey, D.; Woo, K.; Voss, M.; Hsieh, J.; Feldman, D.; Motzer, R.
BJU International (2016)

Fulltext@MSK | Save

Differential overall survival results in RECORD-3 study based on three distinct clear cell metastatic renal cell carcinoma molecular subgroups classified by BAP1 and/or PBRM1 mutations